ESC Premium Access

Lack of low-density lipoprotein cholesterol (LDL-C) goal attainment among high-risk patients using high or moderate intensity statin therapy in Germany

Presentation

About the speaker

Doctor Maximilian Hatz

Munich (Germany)
0 follower

4 more presentations in this session

Discussant: Best Posters in new targets in cardiovascular drug assessment

Thumbnail

Individual-specific corrected QT interval (QTcI) obtained from ECGs recorded at fixed timepoints versus QTcI derived using a wider range of stable heart rates from 24-hour Holter recordings

Speaker: Doctor R. Turner (Durham, US)

Thumbnail

Initial clinical experience with AZD5718, a novel once daily oral 5-lipoxygenase activating protein (FLAP) inhibitor, intended for patients with coronary artery disease

Speaker: Associate Professor S. Skrtic (Molndal, SE)

Thumbnail

Role of ivabradine in development of new onset atrial fibrillation in acute coronary syndrome patients

Speaker: Doctor A. Almaghraby (Alexandria, EG)

Thumbnail

Access the full session

Best Posters 3 - Best Posters in new targets in cardiovascular drug assessment

Speakers: Doctor M. Hatz, Doctor R. Turner, Associate Professor S. Skrtic, Doctor A. Almaghraby
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk